Labcorp Holdings Inc. LH has agreed to acquire the prenatal health testing business of Myriad Genetics Inc. MYGN in an ...
Labcorp is outlaying up to $872m to acquire certain laboratory assets from OPKO Health subsidiary BioReference Health, ...
Labcorp has agreed to acquire select BioReference Health assets from OPKO Health in a transaction that includes $722 million ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and Labcorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, ...
Labcorp has launched the Thrive 5 Health Test that is now offered through a collaboration with Arianna Huffington's behavior ...
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of the ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp® (NYSE: LH), a leading global life sciences company, today announced a new collaboration with HealthVerity, Inc., the ...
Labcorp Holdings Inc. (NYSE:LH) earns fees from routine and specialty medical tests and laboratory services supporting drug ...
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2026 before the market opens on ...
In my follow-up article on Labcorp, I am upgrading it to a 'Buy' this time. Macro forecasts and the firm's own portfolio growth of solutions and locations could drive more tailwinds to the top line.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results